Back to results
CompletedPhase 1

Safety, Tolerability and Pharmacokinetics Study of LY03005

NCT02055300

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Medpace

Cincinnati, Ohio, United States

View on ClinicalTrials.gov
Safety, Tolerability and Pharmacokinetics Study of LY03005 — TrialFind